Efficacy of SGLT2 Inhibitors in Reducing Hospitalization for Heart Failure in Patients with Type 2 Diabetes: A Meta-Analysis. Vascular and Endovascular Review, [S. l.], v. 8, n. 1s, p. 47–52, 2025. Disponível em: https://verjournal.com/index.php/ver/article/view/97. Acesso em: 26 feb. 2026.